⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.
Mupirocin ointment
پماد موپیروسین
🧴 DermatologicalsTopical antibiotic
🤰 Pregnancy:Use with caution🤱 Breastfeeding:No specific problem stated👶 Children:Use with caution 🇮🇷 Registered in Iran⛔ 2 contraindications 🇺🇸 FDA approved generic (ANDA) ANDA065123ATC D06AX09
Market / country: 🇺🇸 USA
Bactroban (US)
🧮 Dose calculator
Impetigo · Regimen source: FDA Mupirocin · 2
- • Small amount with a cotton swab or gauze. Re-evaluate if no response in 3–5 days. Not for nasal, ophthalmic or mucosal use. FDA Mupirocin · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to mupirocin. FDA Mupirocin · 4
- ⛔ Not established under 2 months. FDA Mupirocin · 8.4
Formulations
- 2% ointment (20 mg/g) — ointment 🇺🇸 USA FDA Mupirocin · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Mupirocin · 8.1
“Risk Summary There are insufficient human data to establish whether there is a drug-associated risk with mupirocin ointment in pregnant women.”
- 🤱 BreastfeedingNo specific problem stated
Label: infant exposure not expected. FDA Mupirocin · 8.2
“However, breastfeeding is not expected to result in exposure of the child to the drug due to the minimal systemic absorption of mupirocin in humans following topical administration of mupirocin ointment [ see Clinical Pharmacology (12.3) ].”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Mupirocin · 8.4
“The safety and effectiveness of mupirocin ointment have been established in the age range of 2 months to 16 years.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA065123
- DailyMed (FDA label)FDA Mupirocin
- MedlinePlus (NIH)Mupirocin topical
- WHO ATC/DDDD06AX09
- Darooyab (Iran)Mupirocin
🇮🇷 Registered in Iran Darooyab · G-445/Mupirocin
Dosage forms with Iranian generic codes, per Darooyab.
- 00875 · MUPIROCIN 2% 15G OINT · پماد موپیروسین ۲ درصد ۱۵ گرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Mupirocin · 3FDA Mupirocin · 2FDA Mupirocin · 4FDA Mupirocin · 8.4FDA Mupirocin · 8.1FDA Mupirocin · 8.2FDA Mupirocin · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-445/Mupirocin
- Clinical review⚠ Unverified